🔗 Share this article

The Nobel Prize in medical science was granted for transformative findings that clarify how the immune system targets dangerous pathogens while protecting the body's own cells.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—received this honor.

Their research uncovered specialized "sentinels" within the defense system that eliminate malfunctioning defense cells capable of harming the body.

These discoveries are now enabling new therapies for immune disorders and cancer.

These laureates will share a monetary award worth 11 million Swedish kronor.

Decisive Discoveries

"Their research has been essential for understanding how the body's defenses functions and the reason we do not all suffer from serious self-attack conditions," commented the chair of the award panel.

The team's studies explain a core question: In what way does the immune system defend us from countless invaders while keeping our own tissues unharmed?

The immune system employs white blood cells that search for signs of disease, including viruses and bacteria it has not met before.

These defenders utilize sensors—known as receptors—that are generated randomly in a vast number of variations.

This gives the defense network the ability to combat a broad range of threats, but the unpredictability of the process unavoidably creates immune cells that can attack the host.

Security Guards of the Immune System

Researchers earlier understood that some of these problematic white blood cells were destroyed in the immune organ—the site where immune cells mature.

The latest Nobel Prize recognizes the identification of regulatory T-cells—described as the immune system's "security guards"—which travel through the body to neutralize any immune cells that attack the healthy cells.

It is known that this process malfunctions in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "The findings have established a novel area of investigation and spurred the creation of innovative treatments, for instance for cancer and immune disorders."

Regarding malignancies, regulatory T-cells block the system from fighting the tumor, so studies are focused on reducing their quantity.

For autoimmune diseases, trials are exploring increasing T-reg cells so the organism is no longer under attack. A similar method could also be effective in reducing the risks of organ transplant rejection.

Pioneering Experiments

Professor Sakaguchi, of a Japanese institution, conducted tests on mice that had their thymus extracted, causing self-attack conditions.

He showed that injecting immune cells from other animals could stop the illness—suggesting there was a system for preventing immune cells from attacking the body.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at a biotech firm in a California city, were studying an inherited immune disorder in mice and people that led to the identification of a genetic factor critical for how regulatory T-cells operate.

"Their groundbreaking research has revealed how the immune system is kept in check by regulatory T cells, preventing it from accidentally attacking the healthy cells," commented a leading biological science specialist.

"This work is a remarkable example of how fundamental biological study can have far-reaching consequences for human health."